Curcumin, an active compound in turmeric, has been known for its anti-inflammatory and anti-oxidant properties. Researchers from UCLA/VA found that curcumin may help the immune system clear the brain of the amyloid beta plaques found in Alzheimer's disease patients.
The findings have recently been published in the Journal of Alzheimer's Disease which may lead to a new approach in treating Alzheimer's disease by enhancing the natural function of the immune system using curcumin.
Bioponic Phytoceuticals, Inc. (OTC: BPYT) recently announced that its Curecumin™ product (a Bioresonant Phytotherapeutic™ form of Turmeric) may be an important treatment and/or preventative for Alzheimer's Disease.
According to Steven M. Schorr, Chairman & CEO of Bioponic Phytoceuticals, Inc.:
"We are particularly interested in the potential of our Curecumin™ nasal spray to deliver its benefits directly to the brain through the nasal cavity. If proven effective, we may have an efficacious, cost effective, natural treatment for the millions of Alzheimer's sufferers, and for those who seek to prevent the disease. With 75 million aging baby boomers the potential for this product is significant.”
Focusing on the production of natural products that are used to promote health and well-being, Bioponic Phytoceuticals is the developer, manufacturer and distributor of Bioresonant Phytotherapeutic™ products (a new healing modality) for sale in the Complementary Alternative Medicine ("CAM") and natural products markets.
Source: PR Newswire
.jpg)
Comment Preview